Name, professional designation (MD/PhD/other), institution/organization, professional role, email, work setting, field of research/specialty, disease state, gender, and ethnicity.

NIH Biosketch or equivalent (maximum 5 pages)

Please tell us why you are interested in this workshop in 500 words or less. Please include:

• A description of your career path up to this point and your aspirations for its future.
• Background and experience in cancer immunotherapy, including current research and clinical projects.
• A brief overview of your proposed clinical trial protocol in cancer immunotherapy research and development.
• Trial reagent availability support currently available and plans to seek funding.

Must provide a statement of support stating that the applicant will have time and relevant resources provided to conduct or oversee their trial (e.g. research nurse, appropriate equipment, etc.).

• The candidate’s role and academic or other appointment(s)
• A brief description of the proposed clinical trial
• Program support now available or intended for the term of the trial

A one-page (approximately 500 word) summary of your proposed interventional study. Please include:

1. The unmet clinical need you will be addressing including the target patient population
2. Trial objectives and endpoints
3. Immunologic and other biomarkers proposed (essential, contextual, and emergent/experimental
4. The study design, including the planned number of patients (with justification for sample size) and 
   timeline for enrollment

Applicants must review and acknowledge a confidentiality statement.

The Society for Immunotherapy of Cancer (SITC) and the Pancreatic Cancer Action Network (PanCAN) are pleased to support a travel award for a selected participant of the SITC Clinical Immuno-Oncology Network (SCION) program whose work focuses on pancreatic cancer or has the potential to impact pancreatic cancer patient outcomes.

The award recipient will receive reimbursement for eligible travel expenses to the SCION 2025 program and complimentary registration for the SCION 2025 program.

Application Process

Interested applicants must submit an application to the SCION program. The application period is April 22 through Aug. 5, 2024. Selected applicants that meet the SCION Travel Award Eligibility Criteria will be considered for the award. The award recipient will be notified of the decision in September 2024.

SCION Travel Award Eligibility Criteria

• Eligible applicants include, but are not limited to, clinical fellows and junior faculty/attendings with medical, surgical, radiation, urologic, gynecologic, or pediatric oncology training. We also accept advanced degree scientists (e.g., Masters, PhD, PharmD, DNP) with research experience and interest in clinical and translational immuno-oncology.
• Eligible applicants’ work must focus on pancreatic cancer research or have the potential to impact pancreatic cancer patient outcomes.
• Applications from those working in industry will not be considered for the travel award.

Established in 2022 in loving memory of Dr. Martin “Mac” Cheever, this fund recognizes his many contributions to the field of cancer immunotherapy by providing travel awards to deserving early career investigators pursuing excellence in clinical trial design.

A second award will be selected from the participants in the SCION Workshop. One award will be given to the participant deemed to have the most simple and elegant protocol. The second award will be focused on primary immunoprevention and immune interception. For this award, SITC will consider a trial with protocols which address immunotherapies to prevent primary cancer, including (but not limited to) methods to identify and stimulate immune recognition of precursor or preneoplastic lesions, strategies to provide prophylactic immunity against cancer, immunotherapies for precancerous conditions or immunoprevention of their recurrence in patients with high-risk familial cancers. Protocols for smaller pilot studies will also be considered. 

Both awardees will receive travel reimbursement to the SITC 40^th Anniversary Annual Meeting (SITC 2025) through SITC’s Forward Fund.

The 90-day reports demonstrating progress on participants’ protocols will be used, in part, to select two recipients for the Martin “Mac” Cheever Excellence in Clinical Trial Design Travel Awards. One awardee will be selected from the SCION participants for having the most “simple and elegant” protocol. The second award will be given to the participant whose protocol focuses on immunoprevention/immune interception. The awardees will receive flight, hotel, and meal reimbursement to fully support his/her travel to the SITC 2025 Annual meeting.

Application Submissions Close
Aug. 5, 2024

Applicants Notified
September 2024

Two Virtual Pre-Meetings with Assigned Small Group
January (Day/Time TBD)

SCION Workshop in Austin, TX
February 11-14, 2025

SCION Post Program Meeting
February 2025